京都医療センター
医療関係者の方
交通アクセスはこちら
病院紹介
外来・入院案内
診療科・部門紹介
地域医療連携
看護部
採用情報
京都医療センター

臨床研究センター

内分泌代謝高血圧研究部メニュー

内分泌代謝高血圧研究部

発表論文

全102件中　全件表示

もどる

原著（英文）

2018年
  1. Ohara T, Hata J, Tanaka M, Honda T, Yamakage H, Yoshida D, Inoue T, Hirakawa Y, Kusakabe T, Shibata M, Teraoka T, Kitazono T, Kanba S, Satoh-Asahara N, Ninomiya T. Serum soluble TREM2 as a biomarker for incident dementia: the Hisayama Study. Annals of Neurology doi: 10.1002/ana.25385. [Epub ahead of print] 2018.
  2. Komiyama M, Ozaki Y, Wada H, Yamakage H, Satoh-Asahara N, Morimoto T, Shimatsu A, Takahashi Y, Hasegawa H. The effects of dietary instruction on cardiovascular risk markers after smoking cessation: Study protocol for a multicenter randomized controlled trial in Japan. Trials, accepted.
  3. Komiyama M, Wada H, Yamakage H, Satoh-Asahara N, Sunagawa Y, Morimoto T, Ozaki Y, Shimatsu A, Takahashi Y, Hasegawa K. Analysis of Changes on Adiponectin Levels and Abdominal Obesity after Smoking Cessation. PloS One, 13(8) :e0201244, 2018.
  4. Komiyama M, Yamakage H, Satoh-Asahara N, Ozaki Y, Morimoto T, Shimatsu A, Takahashi Y, Hasegawa K. Sex differences in Nicotine Dependency and Depressive Tendency amoung Smokers. Psychiatry Research, 267, 154-159, 2018
  5. Komiyama M, Miyazaki Y, Wada H, Iguchi M, Abe M, Ogawa H, Akao M, Yamakage H, Satoh-Asahara N, Sunagawa Y, Morimoto T, Hasegawa K. A study on indices of apixaban anticoagulation: A single-center prospective study. J Pharmacol Sci. pii: S1347-8613(18), 2018.
  6. Tanaka M, Masuda S, Yamakage H, Inoue T, Ohue-Kitano R, Yokota S, Kusakabe T, Wada H, Sanada K, Ishii K, Hasegawa K, Shimatsu A, Satoh-Asahara N. Role of serum myostatin in the association between hyperinsulinemia and muscle atrophy in Japanese obese patients. Diabetes Res Clin Pract. 42:195-202,2018.
  7. Wada M, Kita M, Kawasaki K, Kusakabe T, Tagami T, Satoh-Asahara N, Shimatsu A, Hashimoto K. False-positive TSH receptor antibody -a pitfall of third-generation TSH receptor antibody measurements in neonates. Endcr J, [Epub ahead of print], 2018.
  8. Komiyama M, Takanabe R, Ono K, Shimada S, Wada H, Yamakage H, Satoh-Asahara N, Morimoto T, Shimatsu A, Takahashi Y, Hasegawa K. Association between monocyte chemoattractant protein-1 and blood pressure in smokers. J Int Med Res, 46(3), 2018.
  9. Ohue-Kitano R, Yasuoka Y, Goto T, Kitamura N, Si-Bum P, Kishino S, Kimura I, Kasubuchi M, Takahashi H, Li Y,Yeh Y-S, Jheng H-F, Iwase M, Tanaka M, Masuda S, Inoue T, Yamakage H, Kusakabe T, Tani F, Shimatsu A, Takahashi N, Ogawa J, Satoh-Asahara N, Kawasa T. α-Linolenic acid-dereved metabolites from gut lactic acid bacteria induce differentiation of anti-inflammatory M2 macrophages through G prptein-coupled receptor 40. FASEB J, 32(1):304-308, 2018.
  10. Sunagawa Y, Okamura N, Miyazaki Y, Shimizu K, Genpei M, Funamoto M,, Shimizu S, Katanasaka Y, Morimoto E, Yamakage H, Komiyama M, Satoh-Asahara N, Wada H, Suzuki M, Hasegawa K, Morimoto T. Effects of products containing Bacillus subtilis var. natto on healthy subjects with neck and shoulder stiffness, a double-blind, placebo-controlled, randomized crossover study. Biol Pharm Bull, 41(4), 504-509, 2018.
  11. Hashimoto K, Nishihara E, Matsumoto M, Matsumoto S, Nakajima Y, Tsujimoto K, Yamakage H, Satoh-Asahara N, Noh JY, Ito K, Miyauchi A, Mori M, Yamada M, Ogawa Y. Sialic Acid-Binding Immunoglobulin-Like Lectin1 as a Novel Predictive Biomarker for Relapse in Graves' Disease: A Multicenter Study. Thyroid, 28(1), 50-59, 2018.
  12. Masuda S, Tanaka M, Inoue T, Kitano R, Yamakage H, Muranaka K, Kusakabe T, Shimatsu A, Hasegawa K, Satoh-Asahara N. Chemokine(C-X-C motif) ligand 1 is a myokine induced by palmitate and is required for myogenesis in mouse satellite cells. Acta Physiologica, 222(3), 2018.
  13. Komiyama M, Wada H, Ono K, Yamakage H, Satoh-Asahara N, Shimada S, Akao M, Morimoto T, Shimatsu A, Takahashi Y, Sawamura T, Hasegawa K. Smoking cessation reduces the lectin-like low-density lipoprotein receptor index, an independent cardiovascular risk marker of vascular inflammation. Heart Vessels, 33(1), 9-16, 2018.
2017年
  1. Tanaka M, Hajime Y, Masuda S, Inoue T, Kitano Ohue-Kitano R, Araki R, Matoba Y, Saito M, Nagaoka T, Yonezawa K, Tanaka T, Suzuki M, Sawamura M, Nishimura M, Odori S, Wada H, Kotani K, Kusakabe T, Shimatsu A, Hasegawa K, Satoh-Asahara N. Serum soluble TREM2 is a potential novel biomarker of cognitive impairment in Japanese non-obese diabetic patients. Diabetes & Metabolism. In press, 2017.
  2. Inoue R, Ohue-Kitano R, Tsukahara T, Tanaka M, Masuda S, Inoue T, Yamakage H, Kusakabe T, Hasegawa K, Shimatsu A, Satoh-Noriko A. Prediction of functional profiles of gut microbiota from 16S rRNA metagenomic data provides a more robust evaluation of gut dysbiosis occurring in Japanese type 2 diabetic patients. JCBN, In press.
  3. Ito H, Sato T, Satoh-Asahara N, Noda M. Erratum to: Impact of medication adherence on renal function in comorbid patients with type 2 diabetes and depression: protocol for a cohort study. BMC Fam Pract. 10;18(1):61, 2017.
  4. Takayuki Inoue, Masashi Tanaka, Shinya Masuda, Ryuji Ohue-Kitano, Hajime Yamakage,Kazuya Muranaka, Hiromichi Wada, Toru Kusakabe, Akira Shimatsu, Koji Hasegawa, Noriko Satoh-Asahara. Omega-3 polyunsaturated fatty acids suppress the　inflammatory responses of lipopolysaccharide-stimulated mouse microglia by activating SIRT1 pathways. Biochimica et Biophysica Acta 1862 (5)552-560. 2017.
2016年
  1. Murata T, Tsuzaki K, Nirengi S, Watanabe T, Mizutani Y, Okada H, Tsukamoto M, Odori S, Nakagawachi R, Kawaguchi Y, Yoshioka F, Yamada K, Shimatsu A, Kotani K, Satoh-Asahara N, Sakane N. Diagnostic accuracy of the anti-glutamic acid decarboxylase antibody in type 1 diabetes mellitus: Comparison between radioimmunoassay and enzyme-linked immunosorbent assay. J Diabetes Investig doi: 10.1111/jdi.12594. [Epub ahead of print], 2016.
  2. Komiyama M, Shimada S, Wada H, Yamakage H, Satoh-Asahara N, Shimatsu A, Akao M, Morimoto T, Takahashi Y, Hasegawa K. Time-dependent Changes of Atherosclerotic LDL Complexes after Smoking Cessation. J Atheroscler Thromb vol.23 [Equb ahead of print],2016. (IF= 2.770)
  3. Murakami T, Miyachi M, Iemitsu M, Murakami H, Kawano H, Gando Y, Kawakami R, Ishii K, Satoh-Asahara N, Sanada K. Med Sci Sports Exerc. Indexes for Sarcopenia and Obesity Have The Difference Association with Metabolic Syndrome Risk Factors.: 1353 Board #6 June 2, 8: 00 AM - 9: 30 AM. Med Sci Sports Exerc. 48(5 Suppl 1):355,2016. (IF= 4.041)
  4. Funamoto M, Sugawara Y, Katanasaka Y, Miyazaki Y, Imaizumi A, Kakeya H, Yamakage H, Satoh-Asahara N, Komiyama M, Wada H, Morimoto T. Highly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels in patients with mild COPD. International Journal of COPD in press, 2016.
  5. Satoh-Asahara N, Ito H, Akashi T, Yamakage H, Kotani K, Nagata D, Nakagome K, Noda M. A patient-held medical record integrating depression care into diabetes care. Japanese Clinical Medicine in press, 2016.
  6. Miyazaki Y, Katanasaka Y, Sunagawa Y, Sae Hirano, Funamoto M, Morimoto E, Komiyama M, Shimatsu A, Satoh-Asahara N, Yamakage H, Wada H, Hasegawa K, Morimoto T. Effect of Statins on Atherogenic Serum Amyloid A and α1-Antitrypsin Low-Density Lipoprotein Complexes. International Journal of Cardiology in Submitted, 2016.
  7. Tanaka M, Masuda S, Matsuo Y, Sasaki Y, Yamakage H, Muranaka K, Wada H, Hasegawa K, Rsukahara T, Shimatsu A, Satoh-Asahara N. Hyperglycemia and Inflammatory Proerty of Circulating Monocytes are Associated with Inflammatory Property of Carotid Plaques in Patients Undergoing Carotid Endarterectomy. J Atheroscler Thromb in press, 2016.
2015年
  1. Ido A, Nakayama Y, Ishii K, Iemitsu M, Sato K, Fujimoto M, Kurihara T, Hamaoka T, Satoh-Asahara N, Sanada K. Ultrasound-Derived Abdominal Muscle Thickness Better Detects Metabolic Syndrome Risk in Obese Patients than Skeletal Muscle Index Measured by Dual-Energy X-Ray Absorptiometry. PLoS ONE 10(12):e0143858, 2015.
  2. Tanaka M, Matsuo Y, Yamakage H, Masuda S, Terada Y, Muranaka K, Wada H, Hasegawa K, Shimatsu A, Satoh-Asahara N. Differential effects of GLP-1 receptor agonist on form cell formation in monocytes between Non-obese and obese subjects. Metabolism11(10):EJ15-0498, 2015.
  3. Morimoto T, Katanasaka Y, Sunagawa Y, Hirano S, Miyazaki Y, Funamoto M, Hojo Y, Suzuki H, Morimoto E, Ueno M, Shimatsu A, Satoh-Asahara N, Yamakage H, Wada H, Hasegawa K. Effects of statins on left ventricular diastolic function in patients with dyslipidemia and diastolic dysfunction (stat-LVDF study). Biol Pharm Bull 38:1404-1409, 2015.
  4. Satoh-Asahara N, Kotani K, Yamakage H, Yamada T, Araki R, Okajima T, Adachi M, Ooishi M, Shimatsu A. Cardio-Ankle Vascular Index Predicts for the Incidence of Cardiovascular Events in Obese Patients: A multicenter prospective cohort study (Japan Obesity and Metabolic Syndrome Study: JOMS). Atherosclerosis 242(2):461-468, 2015
  5. Kotani K, Satoh-Asahara N, Nakakuki T, Yamakage H, Shimatsu A, Tsukahara T. Association between metabolic syndrome and multiple lesions of intracranial atherothrombotic stroke: a hospital-based study. Cardiovascular Diabetology 14:108, 2015.
  6. Matsuo Y, Tanaka M, Yamakage H, Sasaki Y, Muranaka K, Hata H, Ikai I, Shimatsu A, Inoue M, Chun T-H, Satoh-Asahara N. Thrombospondin 1 as a novel biological marker of obesity and metabolic syndrome. Metabolism 64(11):1490-1499,2015
  7. Ito R, Yamakage H, Kotani K, Wada H, Otani S, Yonezawa K, Ogo A, Okajima T, Adachi M, Araki R, Yoshida K, Saito M, Nagaoka T, Toyonaga T, Tanaka T, Yamada T, Ota I, Oishi M, Miyanaga F, Shimatsu A, Satoh-Asahara N, The Japan Diabetes and Obesity Study (J-DOS) Group. Comparison of Cystatin C- and Creatinine-based Estimated Glomerular Filtration Rate to Predict Coronary Heart Disease Risk in Japanese Patients with Obesity and Diabetes.Endcr J 62:201-207, 2015.
2014年
  1. Komiyama M, Wada H, Ura S, Yamakage H, Satoh-Asahara N, Shimada S, Akao M, Koyama H, Kono K, Shimatsu A, Takahashi Y, Hasegawa K. The effects of weight gain after smoking cessation on atherogenic α1-antitrypsin-low-density lipoprotein. Heart Vessels, 2014. [Epub ahead of print]
  2. Yamakage H, Ito R, Tochiya M, Muranaka K, Tanaka M, Matsuo Y, Odori S, Kono S, Shimatsu A, Satoh-Asahara N. The Utility of Dual Bioelectrical Impedance Analysis in Detecting Intra-abdominal Fat Area in Obese Patients during Weight Reduction Therapy in Comparison with Waist Circumference and Abdominal CT.Endcr J. 61(8):807-819, 2014.
  3. Ito R, Satoh-Asahara N, Yamakage H, Sasaki Y, Odori S, Kono S, Wada H, Suganami S, Ogawa Y, Hasegawa K, Shimatsu A. Increase in EPA/AA ratio associated with improved arterial stiffness in obese patients with dyslipidemia. J Atheroscler Thromb 21:248-260, 2014
2013年
  1. Iguchi A, Yamakage H, Tochiya M, Muranaka K, Sasaki Y, Kono S, Shimatsu A, Satoh-Asahara N. Effect of weight reduction therapy on obstructive sleep apnea syndrome and arterial stiffness in the patients with obesity and metabolic syndrome. J Atheroscler Thromb 25: 807-820, 2013
  2. Komiyama M, Wada H, Ura S, Yamakage H, Satoh-Asahara N, Shimatsu A, Koyama H, Kono K, Takahashi Y, Hasegawa K. Analysis of factors that determine weight gain during smoking cessation therapy.PLoS ONE 8:e72010, 2013
  3. Takanabe-Mori R, Ono K, Wada H, Takaya T, Ura S, Yamakage H, Satoh-Asahara N, Shimatsu A, Takahashi Y, Fujita M, Fujita Y, Sawamura T, Hasegawa K. Lectin-like oxidized low-density lipoprotein receptor-1 plays an important role in vascular inflammation of current smokers.J Atheroscler Thromb, 20:585-590, 2013
  4. Satoh-Asahara N, Shimatsu A, Wada H, Suganami T, Hasegawa K, and Ogawa Y. Response to Comment on: Satoh-Asahara et al. Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients with Dyslipidemia 2012;35:2631-2639. Diabetes Care, 36, e110, 2013
  5. Satoh-Asahara N, Sasaki Y, Wada H, Tochiya M, Iguchi A, Nakagawachi R, Odori S, Kono S, Hasegawa K, Shimatsu A. A Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Exerts Anti-inflammatory Effects in Type 2 Diabetic Patients. Metabolism 62:347-351, 2013
  6. Yamada-Goto N, Katruura G, Ebihara K, Inuzuka M, Ochi Y, Yamashita Y, Kusakabe T, Yasoda A, Satoh-Asahara N, Ariyasu H, Hosoda K, Nakao K. Intracerebroventricular administration of C-type natriuretic peptide suppresses food intake via activation of the melanocortin system in mice. Diabetes 62(3):1500-1504 , 2013
  7. Shirai K, Saiki A, Oikawa S, Teramoto T, Yamada N, Ishibashi S, Tada N, Miyazaki S, Inoue I, Murano S, Sakane N, Satoh-Asahara N, Bujo H, Miyashita Y, Saito Y. The Effect of Partial Use of Formula Diet on Weight Reduction and Metabolic Variables in Obese Type 2 Diabetic Patients-Multicenter Trial-. Obesity Research & Clinical Practice 7:e43-e54,2013
2012年
  1. Satoh-Asahara N, Shimatsu A, Sasaki Y, Nakaoka H, Himeno A, Tochiya M, Kono S, Takaya T, Ono K, Wada H, Suganami T, Hasegawa K, Ogawa Y. Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients with Dyslipidemia. Diabetes Care 35:2631-2639, 2012
  2. Usui T, Tochiya M, Sasaki Y, Muranaka K, Yamakage H, Himeno A, Shimatsu A, Inaguma A, Ueno T, Uchiyama S, Satoh-Asahara N. Effects of natural S-equol supplements on overweight or obesity and metabolic syndrome in the Japanese, based on sex and equol status. Clin Endocrinol (Oxf) 78:365-372, 2012.
  3. Himeno A, Satoh-Asahara N, Usui T, Wada H, Tochiya M, Kono S, Yamada-Goto N, Katsuura G, Hasegawa K, Nakao K, Shimatsu A. Salivary cortisol levels are associated with outcomes of weight reduction therapy in obese Japanese patients. Metabolism, 61:255-261, 2012.
  4. Wada H, Ura S, Satoh-Asahara N, Kitaoka S, Mashiba S, Akao M, Abe M, Ono K, Morimoto T, Fujita M, Shimatsu A, Takahashi Y, Hasegawa K. α1-Antitrypsin- low-density-lipoprotein Serves as a Marker of Smoking-specific Oxidative Stress. J Atheroscler Thromb, 19:47-58, 2012.
2011年
  1. Wada H,Ura S,Kitaoka S,Satoh-Asahara N,Horie T,Ono K,Takaya T,Takanabe-Mori R,Akao M,Abe M,Morimoto T,Murayama T,Yokode M,Fujita M,Shimatsu A,Hasegawa K Distinct Characteristics of Circulating Vascular Endothelial Growth Factor-A and C Levels in Human Subjects. PLoS ONE, 6:e29351,2011.
  2. Kotani K, Satoh-Asahara N, Kato Y, Araki R, Himeno A, Yamakage H, Koyama K, Tanabe T, Oishi M, Okajima T, Shimatsu A, The Japan Obesity Metabolic Syndrome Study (JOMS) Group. Serum Amyloid A Low-density Lipoprotein Levels and Smoking Status in Obese Japanese Patients. J Int Med Res 39: 1917-1922, 2011.
  3. Kotani K, Satoh-Asahara N, Kato Y, Araki R, Himeno A, Yamakage H, Koyama K, Tanabe T, Oishi M, Okajima T, Shimatsu A, The Japan Obesity Metabolic Syndrome Study (JOMS) Group. Remnantt-like particle cholesterol and serum amyloid A-low-density lipoprotein levels in obese subjects with metabolic syndrome. J Clin Lipidol 5:395-400, 2011.
  4. Arai D, Yamaguchi S, Murakami M, Nakakuki T, Fukuda S, Satoh-Asahara N, Tsukahara T. Characteristics of carotid plaque findings on ultrasonography and black blood magnetic resonance imaging in comparison with pathological findings. Acta Neurochir Suppl 112:15-19, 2011.
  5. Ichioka M, Suganami T, Tsuda N, Shirakawa I, Hirata Y, Satoh-Asahara N, Shimoda Y, Tanaka M, Kim-Saijo M, Miyamoto Y, Kamei Y, Sata M, Ogawa Y. Increased Expression of Macrophage-inducible C-type Lectin in Adipose Tissue of Obese Mice and Humans. Diabetes 60:819-826, 2011.
  6. Satoh-Asahara N, Sugamami T, Majima T, Kotani K, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Oishi M, Himeno A, Kono S, Sugawara A, Masakazu H, Ogawa Y, and Shimatsu A, The Japan Obesity Metabolic Syndrome Study (JOMS) Group. Urinary Cystatin C as a Potential Risk Marker for Cardiovascular Disease and Chronic Kidney Disease in Patients with Obesity and Metabolic Syndrome. Clin J Am Soc Nephrol 6:265-273, 2011.
2010年
  1. Kotani K, Satoh N, Yamada T, Gugliucci A. The potential of serum amyloid A-LDL as a novel biomarker for cardiovascular disease risk. Clin Lipidol 5:489-495, 2010.
  2. Kotani K, Satoh N, Yamada K, Taniguchi N, Shimatsu A. The influence of metabolic syndrome and chronic kidney disease on the hemorheology assessed by the microchannel method. J Physiol Anthropol 29:157-160, 2010.
  3. Shimada S, Hasegawa K, Wada H, Terashima S, Satoh-Asahara N, Yamakage H, Kitaoka S, Akao M, Shimatsu A, Takahashi Y. High blood viscosity is closely associated with cigarette smoking and markedly reduced by smoking cessation. Circ J 75:185-189, 2010.
  4. Takanabe-Mori R, Ono K, Sowa N, Wada H, Takaya T, Horie T, Satoh-Asahara N, Shimatsu A, Fujita M, Sawamura T, Hasegawa K. LOX-1 is required for the adipose tissue expression of proinflammatory cytokines in high-fat diet-induced obese mice. Biochem Biophys Res Commun 398:576-580, 2010.
  5. Kotani K, Satoh N, Yamada Y. Bezafibrate and Serum Amyloid A-low-density Lipoprotein Complex in Patients with Type 2 Diabetes Mellitus and Hypertriglyceridemia. Eur J Intern Med 21:e10, 2010.
  6. Satoh N, Shimatsu A, Himeno A, Sasaki Y, Yamakage H, Yamada K, Suganami T, Ogawa Y. Unbalanced M1/M2 Phenotype of Peripheral Blood Monocytes in Obese Diabetic Patients: Effect of Pioglitazone. Diabetes Care 33:e7, 2010.
  7. Wada H, Satoh N, Kitaoka S, Ono K, Morimoto T, Kawamura T, Nakano, T, Fujita M, Kita T, Shimatsu A, Hasegawa K. Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance. Atherosclerosis 208:512-517, 2010.
  8. Wada H, Satoh N, Hasegawa K. Transmitral E/A ratio decreases in association with abdominal fat accumulation in patients with impaired glucose tolerance or mild diabetes without left ventricular hypertrophy. Heart Vessels 25:45-50, 2010.
2009年
  1. Satoh N, Shimatsu A, Kotani K, Himeno A, Majima T, Yamada K, Suganami T, Ogawa Y. Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decrease in serum amyloid A-LDL in metabolic syndrome. Hypertens Res 32:1004-1008, 2009.
  2. Kotani K, Satoh N, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Oishi M, Yamakage H, Yamada K, Hattori M, Shimatsu A. A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndrome. Atherosclerosis 204:526-531, 2009.
  3. Satoh N, Kotani K, Wada H, Himeno A, Shimada S, Sasaki Y, Yamada K, Shimatsu A, Hasegawa K. Unfavorable Blood Rheology Is Closely Associated With Arterial Stiffness in Obese Patients. Endocr J 56:915-918, 2009.
  4. Kasahara M, Mori K, Satoh N, Kuwabara T, Yokoi H, Shimatsu A, Sugawara A, Mukoyama M, Nakao K. Reduction in urinary excretion of neutrophil gelatinase-associated lipocalin by angiotensin receptor blocker in hypertensive patients. Nephrol Dial Transplant 24:2608-2609, 2009.
  5. Majima T, Shimatsu A, Komatsu Y, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K. Effects of risedronate or alfacalcidol on bone mineral density, bone turnover, back pain, and fractures in Japanese men with primary osteoporosis: results of a two-year strict observational study. J Bone Miner Metab 27:168-174, 2009.
  6. Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y, Yoshioka T, Ogawa Y, Imamaki H, Kusakabe T, Ebihara K, Omata M, Satoh N, Sugawara A, Barasch J, Nakao K. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage in glomeruli, proximal and distal nephrons. Kidney Int 75:285-294, 2009.
  7. Kobayashi N, Masuzaki H, Chusho H, Fujimoto M, Ebihara K, Hirata M, Miyanaga F, Tanaka T, Tomita T, Kusakabe T, Yasue S, Ishii T, Tanioka H, Arai N, Miyawaki T, Aono H, Saito N, Satoh N, Nakajima M, Okabayashi Y, Miyata H, Matsuzaki K, Arai H, Hosoda K, Hayashi T, and Nakao K. Index of the Systemic Balance of End Products of Glucocorticoid metabolism in Fresh Urine from Humans – Its Potential Usefulness in the Evaluation of Obesity-related Diseases- Obesity Research and Clinical Practice 3:53-63, 2009.
2008年
  1. Takanabe R, Ono K, Abe Y, Takaya T, Horie T, Wada H, Kita T, Satoh N, Shimatsu A, Hasegawa K. Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet. Biochem Biophys Res Commun 376:728-732, 2008.
  2. Hasegawa K, Terashima S, Satoh N, Inoue M, Wada H, Itoh C, Iida Y, Yamakage H, Shimats A, Takahashi Y. Depressive state of patients on their initial visit to a smoking cessation clinic. Smoking Control Science 2:23-26, 2008.
  3. Wada H, Hasegawa K, Terashima S, Itoh C, Iida Y, Kitaoka S, Satoh N, Nakano T, Shimatsu A, Takahashi Y. Knowledge and interest regarding smoking-related health risks in smokers and non-smokers. Smoking Control Science 2: 5-8, 2008.
  4. Yamada H, Yoshida M, Nakano Y, Suganami T, Satoh N, Mita T, Azuma K, Itoh M, Yamamoto Y, Kamei Y, Horie M, Watada H, Ogawa Y. In vivo and In vitro Inhibition of Monocyte Adhesion to Endothelial Cells and Endothelial Adhesion Molecules by Eicosapentaenoic Acid. Arterioscler Thromb Vasc Biol 28:2173-2179, 2008.
  5. Satoh N, Shimatsu A, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Oishi M, Kotani K, and Ogawa Y, For The Japan Obesity and Metabolic Syndrome Study (JOMS) Group Evaluation of cardio-ankle vascular index, a new indicator of arterial stiffness independent of blood pressure, in obesity and metabolic syndrome. Hypertens Res 31:1921-1930, 2008.
  6. Wada H, Abe M, Ono K, Morimoto T, Kawamura T, Takaya T, Satoh N, Fujita M, Kita T, Shimatsu A, Hasegawa K. Statins activate GATA-6 and induce differentiated vascular smooth muscle cells. Biochem Biophys Res Commun 374:731-736, 2008.
  7. Satoh N, Wada H, Ono K, Yamakage H, Yamada K, Nakano T, Hattori M, Shimatsu A, Kuzuya H, Hasegawa K. Small dense LDL-cholesterol relative to LDL-cholesterol is a strong independent determinant of hypoadiponectinemia in metabolic syndrome. Circ J 72:932-939, 2008.
  8. Majima T, Shimatsu A, Komatsu Y, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K. Efficacy of risedronate in Japanese male patients with primary osteoporosis. Intern Med. 47:717-723, 2008.
  9. Majima T, Komatsu Y, Shimatsu A, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K. Efficacy of combined treatment with raloxifene and alfacalcidol on bone density and biochemical markers of bone turnover in postmenopausal osteoporosis. Endocr J 55:127-134, 2008.
  10. Majima T, Komatsu Y, Shimatsu A, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K. Increased bone turnover in patients with hypercholesterolemia. Endocr J 55:143-151, 2008.
  11. Majima T, Komatsu Y, Shimatsu A, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K. Association between baseline values of bone turnover markers and bone mineral density and their response to raloxifene treatment in Japanese postmenopausal women with osteoporosis. Endocr J 55:41-48, 2008.
  12. Majima T, Komatsu Y, Shimatsu A, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K. 3-month changes in bone turnover markers and bone mineral density response to raloxifene in Japanese postmenopausal women with osteoporosis. J Bone Miner Metab 26:178-184, 2008.
2007年
  1. Majima T, Shimatsu A, Komatsu Y, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K. Short-term effects of pitavastatin on biochemical markers of bone turnover in patients with hypercholesterolemia. Intern Med 46:1967-1973, 2007.
  2. Majima T, Komatsu Y, Shimatsu A, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K. Clinical significance of one-year treatment with raloxifene on bone and lipid metabolism in Japanese postmenopausal women with osteoporosis. Endocr J 54:145-151, 2007.
  3. Itoh M, Suganami T, Satoh N, Tanimoto-Koyama K, Yuan X, Tanaka M, Kawano H, Yano T, Aoe S, Takeya M, Shimatsu A, Kuzuya H, Kamei Y, Ogawa Y. Increased Adiponectin Secretion by Highly Purified Eicosapentaenoic Acid in Rodent Models of Obesity and Human Obese Subjects. Arterioscler Thromb Vasc Biol 27:1918-1925, 2007.
  4. Satoh N, Shimatsu A, Kotani K, Sakane N, Yamada K, Suganami T, Kuzuya H, Ogawa Y. Diabetes Care 30:144-146, 2007.
2006年
  1. Satoh N, Shimatsu A, Yamada K, Aizawa-Abe M, Suginami T, Kuzuya H, Ogawa Y. An α-glucosidase inhibitor voglibose reduces oxidative stress markers and soluble intercellular adhesion molecule-1 in obese type 2 diabetes. Metabolism 55: 786-793, 2006.
2004年
  1. Satoh N, Naruse M, Usui T, Tagami T, Suganami T, Yamada K, Kuzuya H, Shimatsu A, Ogawa Y. Leptin-to-adiponectin Ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care 27: 2488-2490, 2004.
  2. Tagami T, Satoh N, Usui T, Yamada K, Shimatsu A, Kuzuya H. Adiponectin in Anorexia Nervosa and Bulimia Nervosa. J Clin Endocrinol. Metab. 89: 1833-1837, 2004.
〜2003年
  1. Satoh N, Ogawa Y, Usui T, Kohno S, Uesugi H, Sugiyama H, Sugawara A, Yamada K, Shimatsu A, Kuzuya H, Nakao K. Antiatherogenic effect of pioglitazone in type 2 diabetic patients, irrespective of the responsiveness to its antidiabetic effect. Diabetes Care 26: 2493-2499, 2003.
  2. Matsuoka Y, Furuyashiki T, Bito H, Ushikubi F, Tanaka Y, Kobayashi T, Muro S, Satoh N, Kayahara T, Higashi M, Mizoguchi A, Shichi H, Fukuda Y, Nakao K, Narumiya S. Impaired adrenocorticotropic hormone response to bacterial endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes. Proc Natl Acad Sci U.S.A. 100: 4132-4137, 2003.
  3. Matsuoka N, Ogawa Y, Masuzaki H, Ebihara K, Aizawa-Abe M, Satoh N, Ishikawa E, Fujisawa Y, Kosaki A, Yamada K, Kuzuya H, Nakao K. Decreased triglyceride-rich lipoproteins in transgenic skinny mice overexpressing leptin. Am J Physiol Endocrinol Metab 280:E334-E339, 2001.
  4. Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H, Matsuoka N, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Nakao K. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 105:1243-1252, 2000.
  5. Ebihara K, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Satoh N, Tamaki M, Yoshioka T, Hayase M, Matsuoka N, Aizawa-Abe M, Yoshimasa Y, Nakao K. Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action. Diabetes 48:2028-2033, 1999.
  6. Ogawa Y, Masuzaki H, Hosoda K, Aizawa-Abe M, Suga J, Suda M, Ebihara K, Iwai H, Matsuoka N, Satoh N, Odaka H, Kasuga H, Fujisawa Y, Inoue G, Nishimura H, Yoshimasa Y, Nakao K. Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes 48:1822-1829, 1999.
  7. Satoh N, Ogawa Y, Katsuura G, Numata Y, Tsuji T, Hayase M, Ebihara K, Masuzaki H, Hosoda K, Yoshimasa Y, Nakao K. Sympathetic activation of leptin via the ventromedical hypothalamus: leptin-induced increase in catecholamine secretion. Diabetes 48: 1787-1793, 1999.
  8. Masuzaki H, Ogawa Y, Aizawa-Abe M, Hosoda K, Suga J, Ebihara K, Satoh N, Iwai H, Inoue G, Nishimura H, Yoshimasa Y, Nakao K. Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes 48:1615-1622, 1999.
  9. Satoh N, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Yoshimasa Y, Nakao K. Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci Lett 249: 107-110, 1998.
  10. Azuma N, Yoshimasa Y, Nishimura H, Yamamoto Y, Masuzaki H, Suga J, Shigemoto M, Matsuoka N, Tanaka T, Satoh N, Igaki T, Miyamoto Y, Itoh H, Yoshimasa T, Hosoda K, Nishi S, Nakao K. The significance of the Trp64 Arg mutaion of the beta3-adrenergic receptor gene in impaired glucose tolerance, non-insulin-dependent diabetes mellitus, an insulin resistance in Japanese subjects. Metabolism 47:456-466, 1998.
  11. Satoh N, Ogawa Y, Katsuura G, Hayase M, Tsuji T, Imagawa K, Yoshimasa Y, Nishi S, Hosoda K, Nakao K. The arcuate nucleus as a primary site of satiety effect of leptin in rats. Neurosci Lett 224: 149-152, 1997.
  12. Satoh N, Ogawa Y, Katsuura G, Tsuji T, Masuzaki H, Hiraoka J, Okazaki T, M Tamaki, Hayase M, Yoshimasa Y, Nishi S, Hosoda K, Nakao K. Pathophysiological significance of the obese gene product, leptin, in ventromedical hypothalamus (VMH)–lesioned rats: evidence for loss of its satiety effect in VMH-lesioned rats. Endocrinology 138: 947-954, 1997.
  13. Takaya K, Ogawa Y, Isse N, Okazaki T, Satoh N, Masuzaki H, Mori K, Tamura N, Hosoda K, Nakao K. Molecular cloning of rat leptin receptor isoform complementary DNAs-Identification of a missense mutation in Zucker fatty (falfa) rats. Biochem Biophys Res Commun 225: 75-83, 1996.
  14. Masuzaki H, Hosoda K, Ogawa Y, Shigemoto M, Satoh N, Mori K, Tamura N, Nishi S, Yoshimasa Y, Yamori Y, Nakao K. Augmented expression of obese (ob) gene during the process of obesity in genetically obese hyperglycemic Wistar fatty (falfa) rats. FEBS Lett 378:267-271, 1996.
  15. Isse N, Ogawa Y, Tamura N, Masuzaki H, Mori K, Okazaki T, Satoh N, Shigemoto M, Yoshimasa Y, Nishi S, Hosoda K, Imagawa J, Nakao K. Structural organization and chromosomal assignment of the human obese gene. J Biol Chem 270:27728-27733, 1995.
  16. Ogawa Y, Masuzaki H, Isse N, Okazaki T, Mori K, Shigemoto M, Satoh N, Tamura N, Hosoda K, Yoshimasa Y, Nakao K. Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats. J Clin Invest 96:1647-1652,1995.
  17. Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M, Mori K, Tamura N, Hosoda K, Yoshimasa Y, Nakao K. Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 44:855-858, 1995.

原著（和文）

  1. 和田啓道、長谷川浩二、寺嶋幸子、伊藤知明、飯田夕子、佐藤哲子、中野為夫、島津章、高橋裕子. 喫煙の健康への影響に関する知識と関心度アンケート調査. 禁煙科学 2: 5-10, 2008.
  2. 松岡幸代、佐野喜子、津崎こころ、同道正行、岡崎研太郎、佐藤哲子、鮒子田睦子、阿部圭子、東あかね、田嶋佐和子、大石まり子、坂根直樹. 耐糖能異常を伴う肥満者においてフォーミュラ食併用療法が減量と摂取栄養素に及ぼす影響－ランダム化比較試験－. 糖尿病 50: 327-331, 2007.
  3. Hashimoto M, Tagami T, Shigemitsu M, Satoh N, Usui T, Yamada K, Shimatsu A, Kuzuya H, Sugawara A. Case of pseudo-hypoparathyroidism type II with Basedow’s disease. Clin Calcium 14: 122-126, 2004.

もどる

→臨床研究センタートップページ